search
Back to results

Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis (VISAGE)

Primary Purpose

Facial Palsy, Self-rehabilitation, Quality of Life

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Self-rehabilitation program
Conventional rehabilitation program
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Facial Palsy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 17 yo;
  • Ambulatory patient;
  • Motivation to participate to a rehabilitative facial program for six months;
  • Patient consent to shaving (men) and no makeup (women) in order not to hamper evaluations the morning of the 4 visits of the study ;
  • Signed informed consent;
  • Affiliation to asocial security scheme.

Exclusion Criteria:

  • Peripheral facial paresis of evolving tumoral etiology;
  • Medical history of botulinum toxin injections in facial muscles during the last 6 months preceding inclusion or injections planned during the study;
  • Medical history of facial surgery in the last two years preceding inclusion or planned during the study;
  • Medical history of facial reanimation surgery needing specific rehabilitation (V-VII or XII-VII anastomosis or muscle transfer);
  • Medical history of medical aesthetic facial treatments (hyaluronic acid/ lipofilling/laser/bracing wires) in the preceding two years before inclusion or planned during the study;
  • Recurrent PFP;
  • Implication in other research interventional protocol dealing with aesthetical aspect of the face or with PFP;
  • Intercurrent pathology impeding the realization of the rehabilitation program during the study;
  • Cognitive, mental or psychiatric troubles impeding the realization of the rehabilitation program or the capacity to attend both evaluations and follow-up consultations;
  • Tutorship or guardianship patient.

Sites / Locations

  • Centre Hospitalier Intercommunal de CréteilRecruiting
  • Hôpital Henri MondorRecruiting
  • Hôpital Saint-Joseph

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental group

Control group

Arm Description

Self-rehabilitation guided program with investigator PMR specialist

Conventional rehabilitation with a speech therapist or physiotherapist specialized in facial rehabilitation

Outcomes

Primary Outcome Measures

Change of Composite score of the Sunnybook Facial Grading System
estimation of resting symmetry (score 0 to 20), symmetry at voluntary movement (score 20 to 100) and synkinesis (score 0 to 15) composite score = symmetry at voluntary movement - resting symmetry - synkinesis from Day 0 to Day 180. (Ross et al. 1996, PMID: 8649870)

Secondary Outcome Measures

Full Information

First Posted
July 23, 2019
Last Updated
June 10, 2022
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT04074018
Brief Title
Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis
Acronym
VISAGE
Official Title
Clinical, Kinematic and Quality-of-life Related Impacts of Two Rehabilitation Programs in Chronic Peripheral Facial Paresis: a Randomized Control Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Introduction: Peripheral facial paresis (PFP) is a very common disease of various etiologies affecting average adults with no predominance of sex. In 70% of cases, motor recovery is rapid and complete, but in 30% of early PFP, motor symptoms such as paresis and/or abnormal movements (synkinesis, contractures and/or spasms) can live on and jeopardize patients quality of life at medium and even long term. Concerning therapeutic interventions, the rehabilitation patient care of PFP is often restricted to the early stage. A recent randomized controlled study showed that early rehabilitation had a positive impact on motor recovery, specifically in severe motor grades, and could also accelerate time of recovery without exacerbating synkinesis. At chronic stage of the pathology, there is no controlled study testing the effect of motor rehabilitation when deficiencies are often considered as fitted and permanents. Objective: It is well known in other domains that intensive motor strengthening increases cerebral plasticity in general, and particularly that of sensorimotor command. The main hypothesis of the study is that motor strengthening even at chronic stage of PFP could increase motor function and decrease abnormal motor movements through a self-rehabilitation motor program. The main objective is thus to compare the clinical, kinematic and quality-of-life related impacts of two different rehabilitation programs on motor recovery in unilateral PFP at chronic stage (i.e. at least 1 year after injury): a self-rehabilitation program guided by Physical Medicine and Rehabilitation (PMR) therapist versus facial rehabilitation involving physiotherapist or speech therapist specialized in facial rehabilitation. The main evaluation criterion is the evolution of the Sunnybrook Facial Grading Scale composite score between Day0 (before rehabilitation) and Day180 (after 6 months of facial rehabilitation). Method: National, Randomized simple blind controlled study, in two parallel groups: Both program have to be realized daily for 6 months (Day1 to Day180). The population is made of adults with unilateral PFP at chronic stage i.e. at least 1 year from injury. Evaluations and follow-up of patients will be accomplished in a single center: Service de Rééducation Neurolocomotrice de l'Hôpital Mondor in Créteil (France).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Facial Palsy, Self-rehabilitation, Quality of Life, Motor Recovery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are assigned to one of two groups, using computerized randomization, for the duration of the study in each center.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
82 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Self-rehabilitation guided program with investigator PMR specialist
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Conventional rehabilitation with a speech therapist or physiotherapist specialized in facial rehabilitation
Intervention Type
Other
Intervention Name(s)
Self-rehabilitation program
Intervention Description
facial self-rehabilitation for a duration of 6 months
Intervention Type
Other
Intervention Name(s)
Conventional rehabilitation program
Intervention Description
Conventional facial rehabilitation for a duration of 6 months
Primary Outcome Measure Information:
Title
Change of Composite score of the Sunnybook Facial Grading System
Description
estimation of resting symmetry (score 0 to 20), symmetry at voluntary movement (score 20 to 100) and synkinesis (score 0 to 15) composite score = symmetry at voluntary movement - resting symmetry - synkinesis from Day 0 to Day 180. (Ross et al. 1996, PMID: 8649870)
Time Frame
Day 0 and Day 180

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 17 yo; Ambulatory patient; Motivation to participate to a rehabilitative facial program for six months; Patient consent to shaving (men) and no makeup (women) in order not to hamper evaluations the morning of the 4 visits of the study ; Signed informed consent; Affiliation to asocial security scheme. Exclusion Criteria: Peripheral facial paresis of evolving tumoral etiology; Medical history of botulinum toxin injections in facial muscles during the last 6 months preceding inclusion or injections planned during the study; Medical history of facial surgery in the last two years preceding inclusion or planned during the study; Medical history of facial reanimation surgery needing specific rehabilitation (V-VII or XII-VII anastomosis or muscle transfer); Medical history of medical aesthetic facial treatments (hyaluronic acid/ lipofilling/laser/bracing wires) in the preceding two years before inclusion or planned during the study; Recurrent PFP; Implication in other research interventional protocol dealing with aesthetical aspect of the face or with PFP; Intercurrent pathology impeding the realization of the rehabilitation program during the study; Cognitive, mental or psychiatric troubles impeding the realization of the rehabilitation program or the capacity to attend both evaluations and follow-up consultations; Tutorship or guardianship patient.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marjolaine BAUDE, MD
Phone
+0033 1 49 81 30 61
Email
marjolaine.baude@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marjolaine BAUDE, MD
Organizational Affiliation
APHP CHU HENRI MONDOR
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Intercommunal de Créteil
City
Créteil
State/Province
Val De Marne
ZIP/Postal Code
94010
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
André COSTE, MD-PhD
Email
andre.coste@chicreteil.fr
Facility Name
Hôpital Henri Mondor
City
Créteil
State/Province
Val De Marne
ZIP/Postal Code
94010
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marjolaine BAUDE, MD
Email
marjolaine.baude@aphp.fr
Facility Name
Hôpital Saint-Joseph
City
Paris
ZIP/Postal Code
75014
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ludovic BENICHOU, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis

We'll reach out to this number within 24 hrs